These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18481478)

  • 1. Evaluation of brain natriuretic peptide levels in hyperthyroidism and hypothyroidism.
    Ertugrul DT; Gursoy A; Sahin M; Unal AD; Pamuk B; Berberoglu Z; Ayturk S; Tutuncu NB; Demirag NG
    J Natl Med Assoc; 2008 Apr; 100(4):401-5. PubMed ID: 18481478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) in different thyroid function states.
    Schultz M; Faber J; Kistorp C; Jarløv A; Pedersen F; Wiinberg N; Hildebrandt P
    Clin Endocrinol (Oxf); 2004 Jan; 60(1):54-9. PubMed ID: 14678288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of NT-pro-brain natriuretic peptide in patients with overt and subclinical hyperthyroidism and hypothyroidism.
    Pakuła D; Marek B; Kajdaniuk D; Krysiak R; Kos-Kudła B; Pakuła P; Gatnar A; Borgiel-Marek H; Nowak M; Siemińska L; Głogowska-Szeląg J; Ostrowska Z
    Endokrynol Pol; 2011; 62(6):523-8. PubMed ID: 22144219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) levels in hyperthyroidism and hypothyroidism.
    Ozmen B; Ozmen D; Parildar Z; Mutaf I; Bayindir O
    Endocr Res; 2007; 32(1-2):1-8. PubMed ID: 18271501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-A-type and N-terminal pro-B-type natriuretic peptides in different thyroid function states.
    Christ-Crain M; Morgenthaler NG; Meier C; Müller C; Nussbaumer C; Bergmann A; Staub JJ; Müller B
    Swiss Med Wkly; 2005 Sep; 135(37-38):549-54. PubMed ID: 16333765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperthyroidism may affect serum N-terminal pro-B-type natriuretic peptide levels independently of cardiac dysfunction.
    Arikan S; Tuzcu A; Gokalp D; Bahceci M; Danis R
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):202-7. PubMed ID: 17547691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of brain natriuretic peptide release from the heart by thyroid hormone.
    Kohno M; Horio T; Yasunari K; Yokokawa K; Ikeda M; Kurihara N; Nishizawa Y; Morii H; Takeda T
    Metabolism; 1993 Aug; 42(8):1059-64. PubMed ID: 8345811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of serum brain natriuretic peptide in the diagnosis of hyperthyroid heart disease in children].
    Lin XM; Wen FQ; Chen T; Ding L; Zhang XY; Zhang W
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Aug; 11(8):631-4. PubMed ID: 19695186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-type natriuretic peptide in patients with clinical hyperthyroidism.
    Wei T; Zeng C; Tian Y; Chen Q; Wang L
    J Endocrinol Invest; 2005 Jan; 28(1):8-11. PubMed ID: 15816364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreasing brain natriuretic peptide levels after treatment for hyperthyroidism.
    Ertugrul DT; Yavuz B; Ata N; Yalcin AA; Kucukazman M; Algul B; Dal K; Akin KO; Deveci OS; Canbolat N; Ure OS; Tutal E
    Endocr J; 2009; 56(9):1043-8. PubMed ID: 19738361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Thyroid Hormone Levels Within the Normal and/or Subclinical Hyper- or Hypothyroid Range Do Not Affect Circulating Irisin Levels in Humans.
    Panagiotou G; Pazaitou-Panayiotou K; Paschou SA; Komninou D; Kalogeris N; Vryonidou A; Mantzoros CS
    Thyroid; 2016 Aug; 26(8):1039-45. PubMed ID: 27267080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of thyroid dysfunction on brain natriuretic peptide level in health examination participants.
    Ohba K; Okada E; Goto Y; Suzuki S; Machii M; Nonaka D; Matsushita A; Sasaki S; Suda T; Oki Y; Takase H
    Endocr J; 2020 Apr; 67(4):449-454. PubMed ID: 31956210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of thyroid dysfunction on N-terminal pro-B-type natriuretic peptide levels: A systematic review and meta-analysis.
    Zhang H; Li X; Zhang N; Tian L
    Front Endocrinol (Lausanne); 2023; 14():1083171. PubMed ID: 36777339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinol Binding Protein-4 and Adiponectin Levels in Thyroid Overt and Subclinical Dysfunction.
    Kokkinos S; Papazoglou D; Zisimopoulos A; Papanas N; Tiaka E; Antonoglou C; Maltezos E
    Exp Clin Endocrinol Diabetes; 2016 Feb; 124(2):87-92. PubMed ID: 26575118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of atrial natriuretic factor by thyroid hormone: messenger ribonucleic acid and peptide levels in hypothyroid, euthyroid, and hyperthyroid rat atria and ventricles.
    Ladenson PW; Bloch KD; Seidman JG
    Endocrinology; 1988 Jul; 123(1):652-7. PubMed ID: 2968239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF.
    Takami Y; Horio T; Iwashima Y; Takiuchi S; Kamide K; Yoshihara F; Nakamura S; Nakahama H; Inenaga T; Kangawa K; Kawano Y
    Am J Kidney Dis; 2004 Sep; 44(3):420-8. PubMed ID: 15332214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of metabolic syndrome and its components with thyroid dysfunction in Algerian patients.
    Hamlaoui ML; Ayachi A; Dekaken A; Gouri A
    Diabetes Metab Syndr; 2018; 12(1):1-4. PubMed ID: 28843650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
    Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both exogenous subclinical hyperthyroidism and short-term overt hypothyroidism affect myocardial strain in patients with differentiated thyroid carcinoma.
    Abdulrahman RM; Delgado V; Hoftijzer HC; Ng AC; Ewe SH; Marsan NA; Holman ER; Hovens GC; Corssmit EP; Romijn JA; Bax JJ; Smit JW
    Thyroid; 2011 May; 21(5):471-6. PubMed ID: 21417919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone/insulin-like growth factor axis in patients with subclinical thyroid dysfunction.
    Akin F; Yaylali GF; Turgut S; Kaptanoglu B
    Growth Horm IGF Res; 2009 Jun; 19(3):252-5. PubMed ID: 19111490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.